Product Pipeline

Pre-Clinical Phase 1 Phase 2 Phase 3
NH001 - Coma Recovery
NH004 - Sialorrhea
NH02D - Premature Ejaculation

Repurposing Neurologically Active Compounds

NeuroHealing is a clinical stage biopharmaceutical company developing innovative drug treatments for specialty indications based on neurologically active compounds.

NH001 – Coma Recovery

NH001 promotes consciousness and improves the functional outcome of patients in a post-traumatic coma, vegetative state or minimally conscious state.

View details

NH004 – Sialorrhea

NH004 is a novel treatment for sialorrhea (drooling or un-controlled salivation), a major non-motor complaint of Parkinson’s Disease patients.

View details

NH02D – Premature Ejaculation

Premature ejaculation is the most prevalent male sexual disorder affecting 20-30% of sexually active men and is even more prevalent than erectile dysfunction.

View details